DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.

MLA

Hopper, Melissa A., et al. “DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphomas.” Blood Cancer Journal, vol. 14, no. 1, Oct. 2024, p. 172. EBSCOhost, https://doi.org/10.1038/s41408-024-01145-0.

APA

Hopper, M. A., Dropik, A. R., Walker, J. S., Novak, J. P., Laverty, M. S., Manske, M. K., Wu, X., Wenzl, K., Krull, J. E., Sarangi, V., Maurer, M. J., Yang, Z.-Z., Del Busso, M. D., Habermann, T. M., Link, B. K., Rimsza, L. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R., … Novak, A. J. (2024). DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas. Blood Cancer Journal, 14(1), 172. https://doi.org/10.1038/s41408-024-01145-0

Chicago

Hopper, Melissa A, Abigail R Dropik, Janek S Walker, Joseph P Novak, Miranda S Laverty, Michelle K Manske, Xiaosheng Wu, et al. 2024. “DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphomas.” Blood Cancer Journal 14 (1): 172. doi:10.1038/s41408-024-01145-0.